Clinical Trial Update: Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

View source ↗

Summary

A naturalistic safety registry study on celecoxib (Celebrex) and NSAIDs in juvenile arthritis has been terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Juvenile Rheumatoid

Drugs mentioned

• Celecoxib (Celecoxib)
• NSAIDs (non-steroidal anti-inflammatory drugs)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Arthritis, Juvenile Rheumatoid | Status: TERMINATED | Results posted: 2013-07-19